• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    50.12 Up 0.10(0.20%) Jul 31, 4:00PM EDT
    |After Hours : 50.20 Up 0.08 (0.16%) Jul 31, 5:36PM EDT
    Add to Portfolio
    Prev Close:50.02
    Open:50.25
    Bid:42.00 x 600
    Ask:N/A
    1y Target Est:59.67
    Beta:-1.91
    Next Earnings Date:N/A
    Day's Range:49.89 - 52.29
    52wk Range:13.20 - 56.18
    Volume:693,504
    Avg Vol (3m):903,447
    Market Cap:4.28B
    P/E (ttm):N/A
    EPS (ttm):-0.65
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBIX

    Comparison

    Symbol% ChgMkt Cap
    NBIXUp 0.20%4.28B
    ABTDown 0.16%75.47B
    LLYDown 0.04%89.50B
    PFEUp 0.92%222.05B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):216.12
    Ex-Dividend Date:29-Dec-95

    Analysts

    Annual EPS Est (Dec-15) :-0.84
    Quarterly EPS Est (Sep-15) :-0.25
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):6.49

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback